Back to mobile site

Form SCHEDULE 13G/A Fulcrum Therapeutics, Filed by: TCG Crossover GP II, LLC

August 14, 2026 4:30 PM EDT





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
   Rule 13d-1(b)
   Rule 13d-1(c)
   Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



 
TCG Crossover GP II, LLC
 
Signature:/s/ Craig Skaling
Name/Title:Craig Skaling, Authorized Signatory
Date:08/14/2026
 
TCG Crossover Fund II, L.P.
 
Signature:/s/ Craig Skaling
Name/Title:Craig Skaling, Authorized Signatory
Date:08/14/2026
 
Chen Yu
 
Signature:/s/ Craig Skaling
Name/Title:Craig Skaling, as Attorney-in-Fact for Chen Yu
Date:08/14/2026


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

SEC Filings

Related Entities

13G